beta

CWBR

CohBar Inc.

Cwbr

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 03-17-2019 after market close 11-14-2018 after market close 08-14-2018 after market close 05-15-2018 04-02-2018 after market close 11-13-2017 after market close 08-14-2017 after market close
Actual EPS -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.11 -0.08 -0.09 -0.07 -0.07 -0.05
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

CohBar Inc is a research stage biotechnology company. The Company conducts investigational research into Mitochondrial-Derived Peptides to evaluate their therapeutic potential through in vitro and in vivo models.

Market Cap: 255 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.cohbar.com

Shares Outstanding: 39.5 Million

Float: 39.5 Million

Dividend: 0.0 (0.0%)

Beta: 0.470397

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 4.27 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1089 trading days

From: 2018-06-12 To: 2019-06-12

Lowest Point:

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-04 08:38:56:000

Gainers: Castor Maritime (NASDAQ: CTRM ) +39% . CohBar (NASDAQ: CWBR ) +29% . BIOLASE (NASDAQ: BIOL ) +25% . Regional Health Properties (NYSEMKT: RHE ) +25% . Basic Energy Services (NYSE: BAS ) +24% . Soliton (NASDAQ: SOLY ) +21% . CEL-SCI Corporation (NYSEMKT: CVM ) +21% . Su… read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-04 08:38:56:000

Gainers: Castor Maritime (NASDAQ: CTRM ) +39% . CohBar (NASDAQ: CWBR ) +29% . BIOLASE (NASDAQ: BIOL ) +25% . Regional Health Properties (NYSEMKT: RHE ) +25% . Basic Energy Services (NYSE: BAS ) +24% . Soliton (NASDAQ: SOLY ) +21% . CEL-SCI Corporation (NYSEMKT: CVM ) +21% . Su… read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-04 08:38:56:000

Gainers: Castor Maritime (NASDAQ: CTRM ) +39% . CohBar (NASDAQ: CWBR ) +29% . BIOLASE (NASDAQ: BIOL ) +25% . Regional Health Properties (NYSEMKT: RHE ) +25% . Basic Energy Services (NYSE: BAS ) +24% . Soliton (NASDAQ: SOLY ) +21% . CEL-SCI Corporation (NYSEMKT: CVM ) +21% . Su… read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-04 08:38:56:000

Gainers: Castor Maritime (NASDAQ: CTRM ) +39% . CohBar (NASDAQ: CWBR ) +29% . BIOLASE (NASDAQ: BIOL ) +25% . Regional Health Properties (NYSEMKT: RHE ) +25% . Basic Energy Services (NYSE: BAS ) +24% . Soliton (NASDAQ: SOLY ) +21% . CEL-SCI Corporation (NYSEMKT: CVM ) +21% . Su… read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-04 08:38:56:000

Gainers: Castor Maritime (NASDAQ: CTRM ) +39% . CohBar (NASDAQ: CWBR ) +29% . BIOLASE (NASDAQ: BIOL ) +25% . Regional Health Properties (NYSEMKT: RHE ) +25% . Basic Energy Services (NYSE: BAS ) +24% . Soliton (NASDAQ: SOLY ) +21% . CEL-SCI Corporation (NYSEMKT: CVM ) +21% . Su… read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-04 08:38:56:000

Gainers: Castor Maritime (NASDAQ: CTRM ) +39% . CohBar (NASDAQ: CWBR ) +29% . BIOLASE (NASDAQ: BIOL ) +25% . Regional Health Properties (NYSEMKT: RHE ) +25% . Basic Energy Services (NYSE: BAS ) +24% . Soliton (NASDAQ: SOLY ) +21% . CEL-SCI Corporation (NYSEMKT: CVM ) +21% . Su… read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-04 08:38:56:000

Gainers: Castor Maritime (NASDAQ: CTRM ) +39% . CohBar (NASDAQ: CWBR ) +29% . BIOLASE (NASDAQ: BIOL ) +25% . Regional Health Properties (NYSEMKT: RHE ) +25% . Basic Energy Services (NYSE: BAS ) +24% . Soliton (NASDAQ: SOLY ) +21% . CEL-SCI Corporation (NYSEMKT: CVM ) +21% . Su… read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-04 08:38:56:000

Gainers: Castor Maritime (NASDAQ: CTRM ) +39% . CohBar (NASDAQ: CWBR ) +29% . BIOLASE (NASDAQ: BIOL ) +25% . Regional Health Properties (NYSEMKT: RHE ) +25% . Basic Energy Services (NYSE: BAS ) +24% . Soliton (NASDAQ: SOLY ) +21% . CEL-SCI Corporation (NYSEMKT: CVM ) +21% . Su… read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-04 08:38:56:000

Gainers: Castor Maritime (NASDAQ: CTRM ) +39% . CohBar (NASDAQ: CWBR ) +29% . BIOLASE (NASDAQ: BIOL ) +25% . Regional Health Properties (NYSEMKT: RHE ) +25% . Basic Energy Services (NYSE: BAS ) +24% . Soliton (NASDAQ: SOLY ) +21% . CEL-SCI Corporation (NYSEMKT: CVM ) +21% . Su… read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-04 08:38:56:000

Gainers: Castor Maritime (NASDAQ: CTRM ) +39% . CohBar (NASDAQ: CWBR ) +29% . BIOLASE (NASDAQ: BIOL ) +25% . Regional Health Properties (NYSEMKT: RHE ) +25% . Basic Energy Services (NYSE: BAS ) +24% . Soliton (NASDAQ: SOLY ) +21% . CEL-SCI Corporation (NYSEMKT: CVM ) +21% . Su… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar Inc. (CWBR) Interim CEO Philippe Calais on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-10 14:56:29:000

CohBar Inc. (CWBR) Q1 2019 Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Glenn Garmont LifeSci Advisors Philippe Calais Interim Chief Executive Officer Ken Cundy Chief Scientific Officer Jeff Biunno Chief Financial Offi… read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q1 results

via: SeekingAlpha at 2019-05-07 12:12:14:000

CohBar (NASDAQ: CWBR ): Q1 GAAP EPS of -$0.07. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

SBGI, AMG, GIII and ZNH among notable midday movers

via: SeekingAlpha at 2019-05-06 08:53:37:000

Gainers: Aquantia (NYSE: AQ ) +36% . Sinclair Broadcast (NASDAQ: SBGI ) +28% . Athenex (NASDAQ: ATNX ) +25% . Bridgeline Digital (NASDAQ: BLIN ) +22% . Regulus Therapeutics (NASDAQ: RGLS ) +18% . Ovid Therapeutics (NASDAQ: OVID ) +17% . Daxor Corporation (NYSEMKT: DXR ) +17% …. read more...

CohBar up 27% on resumption of clinical trial for lead candidate

via: SeekingAlpha at 2019-05-03 11:28:55:000

Thinly traded micro cap CohBar ( CWBR +27.1% ) is up on a 4x surge in volume, albeit on turnover of only 268K shares, in reaction to the resumption of a Phase 1a/1b study evaluating lead drug CB4211, in development for the potential treatment of nonalcoholic steatohepatitis (NASH) and ob… read more...

CohBar up 27% on resumption of clinical trial for lead candidate

via: SeekingAlpha at 2019-05-03 11:28:55:000

Thinly traded micro cap CohBar ( CWBR +27.1% ) is up on a 4x surge in volume, albeit on turnover of only 268K shares, in reaction to the resumption of a Phase 1a/1b study evaluating lead drug CB4211, in development for the potential treatment of nonalcoholic steatohepatitis (NASH) and ob… read more...

CohBar up 27% on resumption of clinical trial for lead candidate

via: SeekingAlpha at 2019-05-03 11:28:55:000

Thinly traded micro cap CohBar ( CWBR +27.1% ) is up on a 4x surge in volume, albeit on turnover of only 268K shares, in reaction to the resumption of a Phase 1a/1b study evaluating lead drug CB4211, in development for the potential treatment of nonalcoholic steatohepatitis (NASH) and ob… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar Inc. (CWBR) CEO Philippe Calais on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-18 19:20:04:000

CohBar Inc. (CWBR) Q4 2018 Earnings Conference Call March 18, 2019 17:00 ET Company Participants Glenn Garmont - Investor Relations Philippe Calais - Interim Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Pa… read more...

CohBar reports Q4 results

via: SeekingAlpha at 2019-03-18 12:13:07:000

CohBar (NASDAQ: CWBR ): Q4 GAAP EPS of -$0.10. More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 09:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Intercept, Gilead, Pfizer And Genfit In NASH: Overview Of Q1 2019 Catalysts In Liver Therapeutics Investments

via: SeekingAlpha at 2019-02-05 04:28:44:000

Clinical Trials NASH is a progressive chronic liver disease with many causal pathogenic factors. We have learnt from research that dysregulation of the glucose and lipid metabolic pathways could be associated with the development of NASH. Inflammation and activation of the apoptotic (i.e. ce… read more...

Avoid CohBar: Red Flags And An Exorbitant Valuation

via: SeekingAlpha at 2019-02-04 13:31:06:000

MDPs: A Cure-All, or Just Unwarranted Hype? CohBar ( CWBR ) was founded on the premise that dysfunctional mitochondria play a key role in regulating the driving forces behind age-related diseases. According to the thesis touted by the company, mitochondrially secreted peptides have cytoprote… read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

CohBar's (CWBR) CEO Simon Allen on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-14 21:12:19:000

CohBar, Inc. (CWBR) Q3 2018 Earnings Conference Call November 14, 2018 5:00 PM ET Executives Jeff Biunno Chief Financial Officer Simon Allen Chief Executive Officer Ken Cundy Chief Scientific Officer Analysts Presentation Operator Please s… read more...

CohBar's (CWBR) CEO Simon Allen on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-14 21:12:19:000

CohBar, Inc. (CWBR) Q3 2018 Earnings Conference Call November 14, 2018 5:00 PM ET Executives Jeff Biunno Chief Financial Officer Simon Allen Chief Executive Officer Ken Cundy Chief Scientific Officer Analysts Presentation Operator Please s… read more...

CohBar's (CWBR) CEO Simon Allen on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-14 21:12:19:000

CohBar, Inc. (CWBR) Q3 2018 Earnings Conference Call November 14, 2018 5:00 PM ET Executives Jeff Biunno Chief Financial Officer Simon Allen Chief Executive Officer Ken Cundy Chief Scientific Officer Analysts Presentation Operator Please s… read more...

CohBar reports Q3 results

via: SeekingAlpha at 2018-11-14 16:06:49:000

CohBar (NASDAQ: CWBR ): Q3 GAAP EPS of -$0.11. More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Microcaps mostly among midday movers

via: SeekingAlpha at 2018-11-05 12:46:36:000

More news on: Datawatch Corporation, JinkoSolar Holding Co., Ltd., Yulong Eco-Materials, , Stocks on the move, Read more … read more...

Microcaps mostly among midday movers

via: SeekingAlpha at 2018-11-05 12:46:36:000

More news on: Datawatch Corporation, JinkoSolar Holding Co., Ltd., Yulong Eco-Materials, , Stocks on the move, Read more … read more...

Microcaps mostly among midday movers

via: SeekingAlpha at 2018-11-05 12:46:36:000

More news on: Datawatch Corporation, JinkoSolar Holding Co., Ltd., Yulong Eco-Materials, , Stocks on the move, Read more … read more...

CohBar down 39% on suspension of early-stage study of lead NASH candidate

via: SeekingAlpha at 2018-11-05 10:27:23:000

Thinly traded micro cap CohBar ( CWBR -39% ) slumps on more than double normal volume, albeit on turnover of only 229K shares, in reaction to the suspension of a Phase 1 clinical trial evaluating NASH and obesity candidate CB4211. The company took action in order to address mild injectio… read more...

CohBar down 39% on suspension of early-stage study of lead NASH candidate

via: SeekingAlpha at 2018-11-05 10:27:23:000

Thinly traded micro cap CohBar ( CWBR -39% ) slumps on more than double normal volume, albeit on turnover of only 229K shares, in reaction to the suspension of a Phase 1 clinical trial evaluating NASH and obesity candidate CB4211. The company took action in order to address mild injectio… read more...

CohBar down 39% on suspension of early-stage study of lead NASH candidate

via: SeekingAlpha at 2018-11-05 10:27:23:000

Thinly traded micro cap CohBar ( CWBR -39% ) slumps on more than double normal volume, albeit on turnover of only 229K shares, in reaction to the suspension of a Phase 1 clinical trial evaluating NASH and obesity candidate CB4211. The company took action in order to address mild injectio… read more...

CohBar beats by $0.07

via: SeekingAlpha at 2018-08-14 16:18:33:000

CohBar (NASDAQ: CWBR ): Q2 EPS of -$0.08 beats by $0.07 . More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

CohBar beats by $0.07

via: SeekingAlpha at 2018-08-14 16:18:33:000

CohBar (NASDAQ: CWBR ): Q2 EPS of -$0.08 beats by $0.07 . More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

CohBar beats by $0.07

via: SeekingAlpha at 2018-08-14 16:18:33:000

CohBar (NASDAQ: CWBR ): Q2 EPS of -$0.08 beats by $0.07 . More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Technology - Top 5 Gainers / Losers as of 3.05 PM (08/07/2018)

via: SeekingAlpha at 2018-08-07 15:07:19:000

Gainers: IFMK +51% . CWBR +35% . EKSO +30% . FIVN +25% . ONDK +24% . More news on: iFresh Inc., CohBar Inc., Ekso Bionics Holdings, Inc., Tech stocks news, Stocks on the move, Read more … read more...

Technology - Top 5 Gainers / Losers as of 3.05 PM (08/07/2018)

via: SeekingAlpha at 2018-08-07 15:07:19:000

Gainers: IFMK +51% . CWBR +35% . EKSO +30% . FIVN +25% . ONDK +24% . More news on: iFresh Inc., CohBar Inc., Ekso Bionics Holdings, Inc., Tech stocks news, Stocks on the move, Read more … read more...

Technology - Top 5 Gainers / Losers as of 3.05 PM (08/07/2018)

via: SeekingAlpha at 2018-08-07 15:07:19:000

Gainers: IFMK +51% . CWBR +35% . EKSO +30% . FIVN +25% . ONDK +24% . More news on: iFresh Inc., CohBar Inc., Ekso Bionics Holdings, Inc., Tech stocks news, Stocks on the move, Read more … read more...

Midday Gainers / Losers (08/07/2018)

via: SeekingAlpha at 2018-08-07 12:40:10:000

Gainers: IFMK +70% . VCEL +26% . ONDK +25% . EKSO +25% . CVGI +24% . HTZ +24% . MNK +24% . CWBR +24% . TIS +23% . FIVN +22% . More news on: iFresh Inc., Vericel Corporation, OnDeck Capital, Stocks on the move, , Read more … read more...

Midday Gainers / Losers (08/07/2018)

via: SeekingAlpha at 2018-08-07 12:40:10:000

Gainers: IFMK +70% . VCEL +26% . ONDK +25% . EKSO +25% . CVGI +24% . HTZ +24% . MNK +24% . CWBR +24% . TIS +23% . FIVN +22% . More news on: iFresh Inc., Vericel Corporation, OnDeck Capital, Stocks on the move, , Read more … read more...

Midday Gainers / Losers (08/07/2018)

via: SeekingAlpha at 2018-08-07 12:40:10:000

Gainers: IFMK +70% . VCEL +26% . ONDK +25% . EKSO +25% . CVGI +24% . HTZ +24% . MNK +24% . CWBR +24% . TIS +23% . FIVN +22% . More news on: iFresh Inc., Vericel Corporation, OnDeck Capital, Stocks on the move, , Read more … read more...

CohBar (CWBR) Investor Presentation - Slideshow

via: SeekingAlpha at 2018-06-20 13:26:12:000

The following slide deck was published by CohBar Inc. in conjunction with this Read more … read more...

CohBar (CWBR) Investor Presentation - Slideshow

via: SeekingAlpha at 2018-06-20 13:26:12:000

The following slide deck was published by CohBar Inc. in conjunction with this Read more … read more...

CohBar (CWBR) Investor Presentation - Slideshow

via: SeekingAlpha at 2018-06-20 13:26:12:000

The following slide deck was published by CohBar Inc. in conjunction with this Read more … read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

Midday Gainers / Losers (06/01/2018)

via: SeekingAlpha at 2018-06-01 12:40:09:000

Gainers: CODX +92% . CHNR +82% . CLWT +32% . ZUO +20% . LULU +17% . AXON +17% . DHX +15% . TTOO +14% . DDE +13% . CWBR +12% . More news on: Co-Diagnostics, China Natural Resources, Inc., Euro Tech Holdings Company Limited, Stocks on the move, , Read mor… read more...

3 Young Biotechs Positioned To Upend Medicine

via: SeekingAlpha at 2018-05-17 10:51:56:000

Introduction The following three stocks are biotechnology companies that could upend medicine as we know it. The therapeutics they are developing are novel and could be revolutionary. While we recommend buying shares in these stocks, at the prices listed, for a long-term hold, they may not p… read more...

3 Young Biotechs Positioned To Upend Medicine

via: SeekingAlpha at 2018-05-17 10:51:56:000

Introduction The following three stocks are biotechnology companies that could upend medicine as we know it. The therapeutics they are developing are novel and could be revolutionary. While we recommend buying shares in these stocks, at the prices listed, for a long-term hold, they may not p… read more...

3 Young Biotechs Positioned To Upend Medicine

via: SeekingAlpha at 2018-05-17 10:51:56:000

Introduction The following three stocks are biotechnology companies that could upend medicine as we know it. The therapeutics they are developing are novel and could be revolutionary. While we recommend buying shares in these stocks, at the prices listed, for a long-term hold, they may not p… read more...

CohBar reports Q1 results

via: SeekingAlpha at 2018-05-15 16:30:40:000

CohBar (NASDAQ: CWBR ): Q1 EPS of -$0.09 Cash, cash equivalents and investments of of $8.46M Press Release More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, , read more...

CohBar reports Q1 results

via: SeekingAlpha at 2018-05-15 16:30:40:000

CohBar (NASDAQ: CWBR ): Q1 EPS of -$0.09 Cash, cash equivalents and investments of of $8.46M Press Release More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, , read more...

CohBar reports Q1 results

via: SeekingAlpha at 2018-05-15 16:30:40:000

CohBar (NASDAQ: CWBR ): Q1 EPS of -$0.09 Cash, cash equivalents and investments of of $8.46M Press Release More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, , read more...

CohBar reports Q1 results

via: SeekingAlpha at 2018-05-15 16:30:40:000

CohBar (NASDAQ: CWBR ): Q1 EPS of -$0.09 Cash, cash equivalents and investments of of $8.46M Press Release More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, , read more...

CohBar reports Q1 results

via: SeekingAlpha at 2018-05-15 16:30:40:000

CohBar (NASDAQ: CWBR ): Q1 EPS of -$0.09 Cash, cash equivalents and investments of of $8.46M Press Release More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, , read more...

CohBar reports Q1 results

via: SeekingAlpha at 2018-05-15 16:30:40:000

CohBar (NASDAQ: CWBR ): Q1 EPS of -$0.09 Cash, cash equivalents and investments of of $8.46M Press Release More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Lucky Seven: Omeros Moves, Array Biopharma May Be Next

via: SeekingAlpha at 2018-05-08 15:02:53:000

iShares Nasdaq Biotechnology ETF ( IBB ) was good for a 0.3% gain within the last three trading days, while the Lucky Seven netted a 2.6% gain. The Lucky Seven portfolio assumes an investor made a $1000 investment, to begin, in each pick. So, the portfolio began with $7,000. Lucky Seven … read more...

Lucky Seven: Omeros Moves, Array Biopharma May Be Next

via: SeekingAlpha at 2018-05-08 15:02:53:000

iShares Nasdaq Biotechnology ETF ( IBB ) was good for a 0.3% gain within the last three trading days, while the Lucky Seven netted a 2.6% gain. The Lucky Seven portfolio assumes an investor made a $1000 investment, to begin, in each pick. So, the portfolio began with $7,000. Lucky Seven … read more...

CohBar reports Q4 results

via: SeekingAlpha at 2018-04-02 16:39:00:000

CohBar ( OTCQX:CWBR ): Q4 EPS of -$0.07 More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

CohBar reports Q4 results

via: SeekingAlpha at 2018-04-02 16:39:00:000

CohBar ( OTCQX:CWBR ): Q4 EPS of -$0.07 More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

NASH Partnership Could Bring Significant Short-Term Value To CohBar

via: SeekingAlpha at 2018-02-01 15:41:30:000

According to its website : CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepat… read more...

NASH Partnership Could Bring Significant Short-Term Value To CohBar

via: SeekingAlpha at 2018-02-01 15:41:30:000

According to its website : CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepat… read more...

NASH Partnership Could Bring Significant Short-Term Value To CohBar

via: SeekingAlpha at 2018-02-01 15:41:30:000

According to its website : CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepat… read more...

Could CohBar Inc. Hold The Key To Treating Age-Related Disease?

via: SeekingAlpha at 2018-01-24 16:29:42:000

Opportunity & Overview Age-related diseases such Alzheimers, diabetes, and heart disease have proven to be a challenge for pharmaceutical companies to treat using traditional methods. CohBar Inc.s ( OTCQX:CWBR ) team of researchers are studying therapeutically rele… read more...

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

via: PR Newswire at 2018-01-16 07:00:00:000

NEW YORK , Jan. 16, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the fourth quarter 2017 performance and quarterly rebalancing of the OTCQX and OTCQB indexes, includin… read more...

CohBar reports Q3 results

via: SeekingAlpha at 2017-11-13 16:28:31:000

CohBar ( OTCQX:CWBR ): Q3 EPS of -$0.07 Cash and equivalents of $10.34M Press Release More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, , read more...

CohBar, Inc.'s CEO Simon Allen to Present at the 1st Annual H.C. Wainwright & Co. NASH Investor Conference in New York

via: Business Wire at 2017-03-29 17:33:00:000

Senior Management Team to Participate in Hanson Wades Inaugural NASH Summit in Boston CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced t… read more...

CohBar reports Q4 results

via: SeekingAlpha at 2017-03-22 16:13:11:000

CohBar ( OTCQX:CWBR ): Q4 EPS of -$0.05 Cash and equivalents of $8.68M Press Release More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, , read more...

CohBar, Inc. Announces Fourth Quarter 2016 Financial Results

via: Business Wire at 2017-03-22 16:05:00:000

Investor Conference Call Scheduled for Today at 2:00 p.m. PDT/5:00 p.m. EDT CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported financial resu… read more...

CohBar, Inc. to Announce Fourth Quarter 2016 Financial Results and Host Conference Call for Shareholders on March 22, 2017

via: Business Wire at 2017-03-03 11:00:00:000

CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today thatthe Company will release its fourth quarter 2016 financial results on Wednesday, March 2… read more...

CohBar, Inc. Announces Positive Results from Preclinical NASH Study of its Lead Drug Candidates

via: Business Wire at 2017-02-21 08:30:00:000

CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that it has completed a study to evaluate the potential efficacy of its lead drug candidates, MOTS… read more...

CohBar, Inc.'s CEO Simon Allen to Present at the 2017 BIO CEO & Investor Conference in New York

via: Business Wire at 2017-02-09 08:30:00:000

CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today thatits CEO, Simon Allen, will present an overview of the Company and its clinical developme… read more...

CohBar Inc. Presentation Now Available for On-Demand Viewing

via: PR Newswire at 2017-02-06 08:30:00:000

Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation NEW YORK , Feb. 6, 2017 /PRNewswire/ --CohBar Inc. (OTCQX: CWBR and TSXV: COB.U), a Menlo Park, CA based biotechnology company focused … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX